Rigel Pharmaceuticals Form 4 Filing – 10 July 2026

Rigel Pharmaceuticals Inc submitted a Form 4 insider‑transaction filing covering activities on 10 July, with the filing made public on 11 July 2026. The brief Reuters notice records the company’s ticker (RIGL) and notes a 2.77% decline in the share price on the day of the filing. No further information regarding the insiders involved, the number of shares bought or sold, or the transaction price was provided in the article.